6.1 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.743
NA - Nord America 4.491
AS - Asia 795
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 10.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.480
IT - Italia 1.407
SE - Svezia 1.126
IE - Irlanda 759
DE - Germania 406
TR - Turchia 405
UA - Ucraina 370
GB - Regno Unito 229
CN - Cina 204
VN - Vietnam 150
FI - Finlandia 128
CH - Svizzera 114
RU - Federazione Russa 96
AT - Austria 45
EU - Europa 21
AL - Albania 17
BE - Belgio 16
SG - Singapore 15
CA - Canada 11
FR - Francia 11
NL - Olanda 9
KR - Corea 7
IN - India 4
PK - Pakistan 4
HK - Hong Kong 2
HU - Ungheria 2
IR - Iran 2
AU - Australia 1
BG - Bulgaria 1
ES - Italia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
ME - Montenegro 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 10.051
Salva come PNG Salva come JPEG
Città #
Pisa 951
Jacksonville 864
Dublin 759
Chandler 751
Izmir 404
Wilmington 365
Ann Arbor 328
Ashburn 272
Düsseldorf 181
Millbury 176
Boston 169
Dong Ket 150
San Mateo 116
Mestre 108
Bern 92
Woodbridge 85
Seattle 84
Beijing 80
Boardman 80
Dearborn 79
Bremen 76
Lawrence 71
Ogden 66
Scuola 65
Princeton 55
Milan 43
Saint Petersburg 43
Vienna 41
San Giuliano Terme 39
Chicago 35
New York 34
Padova 21
Nanjing 20
Kunming 18
Zurich 18
Hefei 17
Helsinki 16
Brussels 15
Andover 14
Norwalk 14
Bientina 11
Cambridge 11
Fairfield 11
Guangzhou 9
Jinan 8
San Diego 8
Nanchang 7
Seoul 7
Verona 7
Florence 6
Serra 6
Toronto 6
Washington 6
Berlin 5
Centrale 5
Auburn Hills 4
Chengdu 4
Graz 4
Houston 4
Lausanne 4
Shaoxing 4
Zhengzhou 4
Brescia 3
Cascina 3
Chantilly 3
Gorizia 3
Jiaxing 3
Leawood 3
Lodi 3
Lucca 3
Quzhou 3
Rome 3
Trumbull 3
Budapest 2
Castelfranco Veneto 2
Castiglione dei Pepoli 2
Faisalabad 2
Fuzhou 2
Grevenbroich 2
Hanover 2
Lahore 2
Livorno 2
Los Angeles 2
Montreal 2
Mumbai 2
Nanning 2
Piombino 2
Savona 2
Shenyang 2
Tappahannock 2
Taranto 2
Wenzhou 2
Amsterdam 1
Antwerpen 1
Arnsberg 1
Bangalore 1
Bari 1
Bratislava 1
Buffalo 1
Changsha 1
Totale 7.035
Salva come PNG Salva come JPEG
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 177
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 158
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 155
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 153
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 153
Composti particolarmente catalizzatori di poliuretani 141
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 134
Method and device for measuring position and mass 132
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 130
null 129
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 129
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 127
Bucket brigade address decoding architecture for classical and quantum random access memories 121
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 121
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 119
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 114
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 112
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 107
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 106
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 102
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 101
Method for the humanization of antibodies and humanized antibodies thereby obtained 100
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 99
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 98
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 98
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 97
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 96
Method for the humanization of antibodies and humanized antibodies thereby obtained 96
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 96
Laser circolari a semiconduttore con reticoli per emissione verticale 94
INTRACELLULAR ANTIBODIES 92
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 92
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 92
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 91
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 90
Method of identifying a consensus sequence for intracellular antibodies 90
Method for the humanization of antibodies and humanized antibodies thereby obtained. 89
Intracellular selection 89
Method for the potentiation of opioid analgesics effects on pain 88
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 87
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 86
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 86
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 86
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 85
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 85
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 84
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 84
Selection of intracellular immunoglobulins 84
Intracellular selection 83
Intracellular selection 83
Method for the potentiation of opioid analgesics effects on pain 83
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 83
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 83
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 82
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 82
Humanized anti-NGF antibodies 82
Humanized anti-NGF antibodies 82
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 82
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 81
Non-human transgenic animals for the study of neurodegenerative syndromes 81
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 81
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 81
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 81
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 81
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 81
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 80
Method for the humanization of antibodies and humanized antibodies thereby obtained. 80
Method for the humanization of antibodies and humanized antibodies thereby obtained. 80
Method for the humanization of antibodies and humanized antibodies thereby obtained 80
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 80
INTRACELLULAR ANTIBODIES 80
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 79
Humanized anti-NGF antibodies 78
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 78
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 78
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 77
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 77
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 77
Novel analgesic treatment with prolonged effect 76
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 76
Method for the humanization of antibodies and humanized antibodies thereby obtained. 76
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 76
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 76
Selection of intracellular immunoglobulins 76
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 75
Method for the humanization of antibodies and humanized antibodies thereby obtained. 75
Selection of intracellular immunoglobulins 75
Selection of intracellular immunoglobulins 75
Novel analgesic treatment with prolonged effect 74
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 74
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 74
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 74
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 74
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 74
Novel analgesic treatment with prolonged effect 73
Method for the humanization of antibodies and humanized antibodies thereby obtained 71
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 71
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 70
Humanized anti-NGF antibodies 70
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 68
Totale 9.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019414 0 0 0 0 0 0 0 0 0 5 4 405
2019/20201.111 135 105 22 1 132 68 267 42 133 56 127 23
2020/20211.736 129 8 355 10 115 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/2024909 209 48 93 31 53 127 18 119 199 12 0 0
Totale 10.178